Literature DB >> 22136168

Decisions about dendritic cells: past, present, and future.

Ralph M Steinman1.   

Abstract

A properly functioning adaptive immune system signifies the best features of life. It is diverse beyond compare, tolerant without fail, and capable of behaving appropriately with a myriad of infections and other challenges. Dendritic cells are required to explain how this remarkable system is energized and directed. I frame this article in terms of the major decisions that my colleagues and I have made in dendritic cell science and some of the guiding themes at the time the decisions were made. As a result of progress worldwide, there is now evidence of a central role for dendritic cells in initiating antigen-specific immunity and tolerance. The in vivo distribution and development of a previously unrecognized white cell lineage is better understood, as is the importance of dendritic cell maturation to link innate and adaptive immunity in response to many stimuli. Our current focus is on antigen uptake receptors on dendritic cells. These receptors enable experiments involving selective targeting of antigens in situ and new approaches to vaccine design in preclinical and clinical systems.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136168     DOI: 10.1146/annurev-immunol-100311-102839

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  460 in total

1.  TLR7 and TLR9 ligands regulate antigen presentation by macrophages.

Authors:  Teja Celhar; Selma Pereira-Lopes; Susannah I Thornhill; Hui Yin Lee; Manprit K Dhillon; Michael Poidinger; John E Connolly; Lina H K Lim; Subhra K Biswas; Anna-Marie Fairhurst
Journal:  Int Immunol       Date:  2015-11-13       Impact factor: 4.823

2.  A mucin-like peptide from Fasciola hepatica induces parasite-specific Th1-type cell immunity.

Authors:  Verónica Noya; Natalie Brossard; Patricia Berasaín; Ernesto Rodríguez; Carolina Chiale; Daniel Mazal; Carlos Carmona; Teresa Freire
Journal:  Parasitol Res       Date:  2015-12-05       Impact factor: 2.289

3.  Engineered Materials for Cancer Immunotherapy.

Authors:  Alexander S Cheung; David J Mooney
Journal:  Nano Today       Date:  2015-08-01       Impact factor: 20.722

4.  STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.

Authors:  Juan Fu; David B Kanne; Meredith Leong; Laura Hix Glickman; Sarah M McWhirter; Edward Lemmens; Ken Mechette; Justin J Leong; Peter Lauer; Weiqun Liu; Kelsey E Sivick; Qi Zeng; Kevin C Soares; Lei Zheng; Daniel A Portnoy; Joshua J Woodward; Drew M Pardoll; Thomas W Dubensky; Young Kim
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

Review 5.  Human cell-based artificial antigen-presenting cells for cancer immunotherapy.

Authors:  Marcus O Butler; Naoto Hirano
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

6.  Enhancement of anti-tumor CD8 immunity by IgG1-mediated targeting of Fc receptors.

Authors:  Scott N Furlan; Rajakumar Mandraju; Travis Brewer; Kole Roybal; Ty Dale Troutman; Wei Hu; Noah W Palm; Arun Unni; Chandrashekhar Pasare
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 7.  Plant-derived polysaccharides activate dendritic cell-based anti-cancer immunity.

Authors:  Siambi Kikete; Li Luo; Beitian Jia; Li Wang; Gregory Ondieki; Yuhong Bian
Journal:  Cytotechnology       Date:  2018-03-19       Impact factor: 2.058

8.  Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.

Authors:  Xuanming Yang; Xunmin Zhang; May Lynne Fu; Ralph R Weichselbaum; Thomas F Gajewski; Yajun Guo; Yang-Xin Fu
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

9.  Inhibition of SIRPα in dendritic cells potentiates potent antitumor immunity.

Authors:  Qiong Liu; Wen Wen; Liang Tang; Chen-Jie Qin; Yan Lin; Hui-Lu Zhang; Han Wu; Charles Ashton; Hong-Ping Wu; Jin Ding; Wei Dong; Le-Xing Yu; Wen Yang; Dan-Dan Huang; Meng-Chao Wu; Hong-Yang Wang; He-Xin Yan
Journal:  Oncoimmunology       Date:  2016-08-23       Impact factor: 8.110

Review 10.  Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer.

Authors:  Taylor T Chrisikos; Yifan Zhou; Natalie Slone; Rachel Babcock; Stephanie S Watowich; Haiyan S Li
Journal:  Mol Immunol       Date:  2018-03-15       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.